Amanote Research
Register
Sign In
Pcp67 - Regulatory Requirements and Scientific Rationale for Biosimilar: Us vs. European Union.
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.09.542
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2018
Authors
G. Barral
L. Mahi
Publisher
Elsevier BV
Related search
Regulatory and Clinical Experiences With Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada
Oncologist
Cancer Research
Medicine
Oncology
An Overview of Current Regulatory Requirements for Approval of Biosimilar Insulins
Diabetes Technology and Therapeutics
Medicine
Endocrinology
Medical Laboratory Technology
Metabolism
Diabetes
Saudi Crisis for the US & European Union
Scientific and Analytical Herald of IE RAS
Requirements for US Regulatory Approval of the International Thermonuclear Experimental Reactor (ITER)
Towards a Scientific Foundation for Engineering Cognitive Systems – A European Research Agenda, Its Rationale and Perspectives
Biologically Inspired Cognitive Architectures
Cognitive Psychology
Experimental
Artificial Intelligence
Cognitive Neuroscience
Safety-Related Regulatory Actions for Biologicals Approved in the United States and the European Union
JAMA - Journal of the American Medical Association
Medicine
Adaptation of Polish Law on Higher Education to the European Union Requirements
Osvitolohiya
Trade Union Channels for Influencing European Union Policies
Nordic Journal of Working Life Studies
Industrial Relations
Organizational Behavior
Life-course Studies
Life-span
Human Resource Management
Environmental
Public Health
Occupational Health
Scientific Output Scales With Resources. A Comparison of US and European Universities
PLoS ONE
Multidisciplinary
